Browse by Speaker

Type here to filter the list

F
Fabbroni, Chiara

Fondazione IRCCS Istituto Nazionale dei Tumori MILANO
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Chiara Fabbroni
Favorite
Fahs, Assil

Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Assil Fahs
Favorite
Fairweather, Mark

Brigham and Women's Hospital/Harvard Medical School
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Mark Fairweather
Favorite
Fakih, Marwan

City of Hope Comprehensive Cancer Center
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Marwan Fakih
Favorite
Fang, Yan

Memorial Sloan Kettering Cancer Center
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Yan Fang
Favorite
Farag, Mina

McGill University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Mina Farag
Favorite
Farma, Jeffrey

Fox Chase Cancer Center
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jeffrey Farma
Favorite
Farmer, Catherine

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Catherine Farmer
Favorite
Faron, Matthieu

Department of Surgical Oncology, Institut Gustave Roussy
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Matthieu Faron
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Matthieu Faron
Favorite
Feber, Andrew

Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Andrew Feber
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Andrew Feber
Favorite
Federman, Noah

David Geffen School of Medicine, UCLA Jonsson Comprehensive Cancer Center
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Noah Federman
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Noah Federman
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Noah Federman
Favorite
Feig, Barry

University of Texas MD Anderson Cancer Center
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Barry Feig
Favorite
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Barry Feig
Favorite
Feng, Xiaolan

Tom Baker Cancer Centre
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Xiaolan Feng
Favorite
Feng, Xiaolan

BC Cancer
Paper 38 - PATIENT OUTCOMES IN METASTATIC EWING SARCOMA RESTRICTED TO PULMONARY METASTASES TREATED WITH WHOLE LUNG RADIATION
Xiaolan Feng
Favorite
Feng, Xiaolan

Cumming School of Medicine, University of Calgary, Tom Baker Cancer Center
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Xiaolan Feng
Favorite
Fenwick, Nicola

University of Birmingham
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Nicola Fenwick
Favorite
Ferguson, Peter

Department of Surgery, Mount Sinai Hospital; Department of Surgery, University of Toronto; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto; CanSaRCC, Princess Margaret Cancer Centre, Toronto
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Peter Ferguson
Favorite
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Peter Ferguson
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Peter Ferguson
Favorite
Paper 75 - SURGICAL FACTORS TO PREDICT POSTOPERATIVE WOUND COMPLICATIONS IN LOCALIZED SOFT-TISSUE SARCOMAS OF THE EXTREMITY
Peter Ferguson
Favorite
Fernández, Juan Angel

"La Arrixaca" University Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Juan Angel Fernández
Favorite
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Juan Angel Fernández
Favorite
Ferrari, Andrea

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
Andrea Ferrari
Favorite
Ferrari, Stefano

Istituto Ortopedico Rizzoli
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Stefano Ferrari
Favorite
Feuerbach, Lars

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Lars Feuerbach
Favorite
Fice, Michael

Rush University Medical Center
Paper 82 - DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING MODEL FOR PREDICTION OF SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Michael Fice
Favorite
Figueiredo, Rodrigo

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Rodrigo Figueiredo
Favorite
Finch, Alison

Teenage Young Adult AC Unit, University College Hospital MacMillan Cancer Centre, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Alison Finch
Favorite
Fiore, Marco

Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Marco Fiore
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Marco Fiore
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Marco Fiore
Favorite
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marco Fiore
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Marco Fiore
Favorite
Flanagan, Adrienne

University College London Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Adrienne Flanagan
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Adrienne Flanagan
Favorite
Fletcher, Jonathan

Brigham and Women’s Hospital
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Jonathan Fletcher
Favorite
Fleuren, Emmy

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Emmy Fleuren
Favorite
Focaccia, Marco

IRCCS Rizzoli Orthopedic Institute, Orthopedic Oncology Unit
Paper 42 - WHAT FACTORS DIFFERENTIATE EARLY VERSUS LATE PULMONARY METASTASES IN SOFT TISSUE SARCOMA OF THE EXTREMITIES? A COMPARATIVE COHORT ANALYSIS
Marco Focaccia
Favorite
Paper 69 - MAPPING THE COURSE OF RECOVERY FOLLOWING LIMB SALVAGE SURGERY FOR SOFT TISSUE SARCOMA OF THE EXTREMITIES
Marco Focaccia
Favorite
Fordham, Ashleigh

Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
Ashleigh Fordham
Favorite
Ford, Samuel

University Hospitals Birmingham NHS Foundation Trust
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Samuel Ford
Favorite
Fourquet, Fourquet

3. OncoSarc, INSERM U1037, Cancer Research Center in Toulouse,
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Fourquet Fourquet
Favorite
Fox, Amanda

University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Amanda Fox
Favorite
Franza, Andrea

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Andrea Franza
Favorite
Franz, Emily

Molecular, Cellular, and Developmental Biology Graduate Program, The Ohio State University; Center for Childhood Cancer, Nationwide Children’s Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Emily Franz
Favorite
French, Jeremy

The Newcastle upon Tyne Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Jeremy French
Favorite
Fröhling, Stefan

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Stefan Fröhling
Favorite
Frutos-Bernal, MDolores

“La Arrixaca” Clinical University Hospital
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
MDolores Frutos-Bernal
Favorite
Fucimetiere, Francoise

Department of Oncology, Centre Léon Bérard
Paper 44 - REFINING PROGNOSIS IN LOCALIZED GIST: CLINICAL SIGNIFICANCE OF PTEN LOW EXPRESSION AND GENE LOSS
Francoise Fucimetiere
Favorite
Fumagalli, Elena

Istituto Nazionale Tumori
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Elena Fumagalli
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Elena Fumagalli
Favorite
Furness, Andrew

Royal Marsden Hopsital
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Andrew Furness
Favorite
Futreal, P Andrew

The University of Texas MD Anderson Cancer Center
Paper 13 - THE EPIGENETIC IMPACT AND THERAPEUTIC OPPORTUNITY OF AR-DIRECTED THERAPY FOR DSRCT
P Andrew Futreal
Favorite